{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:33:41Z","timestamp":1786545221761,"version":"build-2736575974"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T00:00:00Z","timestamp":1522368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194823","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T17:26:43Z","timestamp":1522430803000},"page":"e0194823","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3944-5915","authenticated-orcid":true,"given":"Marloes","family":"Vissers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alienke J.","family":"Wijmenga-Monsuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Badoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies A.","family":"van Houten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"van der Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A. M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"ref1","article-title":"the forgotten killer of children","author":"TM Wardlaw","year":"2006"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.2009.975","article-title":"Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial","volume":"302","author":"EJ van Gils","year":"2009","journal-title":"Jama"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands","volume":"34","author":"AA Bosch","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":"Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine","volume":"20","author":"SB Black","year":"2001","journal-title":"The Pediatric infectious disease journal"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"E Miller","year":"2011","journal-title":"The Lancet infectious diseases"},{"issue":"16","key":"ref6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"CA Lexau","year":"2005","journal-title":"Jama"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/aje\/kwt156","article-title":"Using pneumococcal carriage data to monitor postvaccination changes in invasive disease","volume":"178","author":"DM Weinberger","year":"2013","journal-title":"American journal of epidemiology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"S Flasche","year":"2011","journal-title":"PLoS Med"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"AB Brueggemann","year":"2004","journal-title":"Journal of infectious diseases"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","article-title":"Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades","volume":"50","author":"ZB Harboe","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3201\/eid1704.101115","article-title":"Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands","volume":"17","author":"J Spijkerman","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis","volume":"7","author":"J Spijkerman","year":"2012","journal-title":"PloS one"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"e0144739","DOI":"10.1371\/journal.pone.0144739","article-title":"Direct comparison of immunogenicity induced by 10-or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants","volume":"10","author":"AJ Wijmenga-Monsuur","year":"2015","journal-title":"PloS one"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","article-title":"World Health Organization Pneumococcal Vaccine Trials Carriage Working G (2003) Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae","volume":"22","author":"K O\u2019Brien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"AM van Deursen","year":"2012","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"MJ Knol","year":"2015","journal-title":"Emerging infectious diseases"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"GH Wagenvoort","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/600045","article-title":"Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome","volume":"49","author":"AG Jansen","year":"2009","journal-title":"Clinical infectious diseases"},{"issue":"38","key":"ref19","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"A Lindstrand","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"T Shiri","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"48","key":"ref21","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1016\/j.vaccine.2011.09.075","article-title":"Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination","volume":"29","author":"W Hanage","year":"2011","journal-title":"Vaccine"},{"issue":"9807","key":"ref22","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"DM Weinberger","year":"2011","journal-title":"The Lancet"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"R Dagan","year":"2013","journal-title":"Clinical infectious diseases"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/cid\/cis922","article-title":"Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D\u2013conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial","volume":"56","author":"MR van den Bergh","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"46","key":"ref25","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil","volume":"34","author":"M-CdC Brandileone","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology","volume":"16","author":"R Isturiz","year":"2017","journal-title":"Expert review of vaccines"},{"issue":"49","key":"ref27","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine","volume":"29","author":"E Miller","year":"2011","journal-title":"Vaccine"},{"key":"ref28","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","author":"I Galanis","year":"2016","journal-title":"European Respiratory Journal"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations","volume":"65","author":"P Naucler","year":"2017","journal-title":"Clinical Infectious Diseases"},{"issue":"34","key":"ref30","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"32","author":"AJ van Hoek","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"MR Moore","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"e0161257","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany","volume":"11","author":"M van der Linden","year":"2016","journal-title":"PloS one"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"I Yildirim","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/JCM.00275-06","article-title":"Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004","volume":"44","author":"A Kronenberg","year":"2006","journal-title":"Journal of clinical microbiology"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10096-011-1247-5","article-title":"Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage","volume":"30","author":"I Rivera-Olivero","year":"2011","journal-title":"European journal of clinical microbiology & infectious diseases"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype\u2013specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"KL Sleeman","year":"2006","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/cid\/ciw357","article-title":"Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics","volume":"63","author":"C Stockmann","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1038\/srep34888","article-title":"Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children","volume":"6","author":"AL Wyllie","year":"2016","journal-title":"Scientific Reports"},{"issue":"20","key":"ref39","first-page":"950","article-title":"High vaccination coverage of the National Immunization Programme in the Netherlands","volume":"153","author":"E Van Lier","year":"2009","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"issue":"52","key":"ref40","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1016\/j.vaccine.2012.04.021","article-title":"Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine","volume":"30","author":"KE Elberse","year":"2012","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:25:20Z","timestamp":1588965920000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194823"}},"subtitle":[],"editor":[{"given":"Jose","family":"Melo-Cristino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,30]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194823","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,30]]}}}